ImmuCell Corporation (ICCC)
ICCCNASDAQ-CMBiotechnology: In Vitro & In Vivo Diagnostic Substances
$10.26
+0.0400 (+0.39%) today
At the close, Nov 10, 4:00 PM ET. After hours $10.06 -1.95%
- Market cap
- $93.18m
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- $10.26 to $10.40
- 52-week range
- $4.52 to $12.10
- Average volume
- 10.5k
- Previous close
- $10.22
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | $5.51m | $7.63m | $10.36m | $7.19m |
| Gross profit | $2.36m | $2.91m | $4.66m | $2.44m |
| Operating income | $20.0k | -$58.0k | $1.97m | $1.94m |
| Net income | -$140.0k | -$2.85m | $1.94m | $1.83m |
Last four quarters: revenue $30.68m, margin 2.6%, free cash flow $4.21m
News
8 latest- ZTS vs. ICCC: Which Animal Health Stock Is the Better Investment Bet?Zacks · Oct 21, 2026
- ImmuCell Reports Preliminary Q3 2026 Sales Growth Of 46%;Stock Up RTTNews · Oct 13, 2026
- The Zacks Analyst Blog Highlights Alphabet, Mastercard, AbbVie, Perma-Pipe and ImmuCellZacks · Sep 29, 2026
- Top Research Reports for Alphabet, Mastercard & AbbVieZacks · Sep 28, 2026
- ImmuCell Stock Falls 8.8% Despite Y/Y Earnings & Sales Growth in Q2Zacks · Aug 27, 2026
- ImmuCell (ICCC) Q2 2026 Earnings Call TranscriptThe Motley Fool · Aug 20, 2026
- ImmuCell Q2 Earnings Call HighlightsMarketBeat · Aug 14, 2026
- Biotech Stocks At 52-Week Highs: AMWL, CUE, ICCC, SRRK, FTH RTTNews · Jul 13, 2026
The company
ImmuCell Corporation (Nasdaq: ICCC) is an animal-health biologics company that operates in the fast-growing market for calf health solutions. It develops, manufactures and commercializes the First Defense® line of products that provides Immediate Immunity through colostrum-derived, orally delivered antibodies against the principal viral and bacterial causes of scours. Scours (neonatal calf diarrhea) is one of the most prevalent and deadly diseases in neonatal calves worldwide.
- Sector
- Health Care
- Industry
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Exchange
- NASDAQ-CM
- Region
- North America
- Website
- immucell.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.